Results 11 to 20 of about 34,931 (220)

Central Adrenal Insufficiency Developing After Right Partial Nephrectomy Involving Ectopic Adrenocortical Adenoma Mimicking Right Renal Carcinoma and a Retrospective Diagnosis of Adrenal Cushing's Syndrome: A Case Report

open access: yesIJU Case Reports
Introduction Ectopic adrenocortical adenomas that produce adrenal hormones and mimic renal cell carcinoma are extremely rare. Case Presentation A 49‐year‐old woman underwent partial nephrectomy of the upper pole of the kidney following a clinical ...
Kentaro Arinami   +8 more
doaj   +2 more sources

Extra-adrenal, non-functional adrenocortical carcinoma presenting with acute abdomen: a case report

open access: yesJournal of Medical Case Reports, 2020
Background Adrenocortical carcinoma is a rare malignancy, with 43% being non-functional. These may arise from adrenal rest anywhere in the embryonic pathway of the adrenal glands.
Alireza Mirsharifi   +4 more
doaj   +1 more source

A case of estrogen‐secreting adrenocortical carcinoma: Comprehensive immunohistochemical analysis of disorganized steroid genesis

open access: yesIJU Case Reports, 2021
Introduction Adrenocortical carcinoma rarely secretes estrogens, and little is known regarding the mechanism of intra‐tumor estrogen production. We report an estrogen‐secreting adrenocortical carcinoma in a postmenopausal woman, where comprehensive ...
Megumi Yokoyama   +8 more
doaj   +1 more source

Estrogen-secreting adrenocortical carcinoma [PDF]

open access: yesYeungnam University Journal of Medicine, 2019
Adrenocortical carcinoma is a rare type of endocrine malignancy with an annual incidence of approximately 1–2 cases per million. The majority of these tumors secrete cortisol, and a few secrete aldosterone or androgen.
You Jeong   +6 more
doaj   +1 more source

Update in Adrenocortical Carcinoma [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 2013
Adrenocortical carcinoma (ACC) is an orphan malignancy that has attracted increasing attention during the last decade. Here we provide an update on advances in the field since our last review published in this journal in 2006.The Wnt/β-catenin pathway and IGF-2 signaling have been confirmed as frequently altered signaling pathways in ACC, but recent ...
Fassnacht, Martin   +2 more
openaire   +2 more sources

Pitfalls and progress in adrenocortical carcinoma diagnosis: the utility of a multidisciplinary approach, immunohistochemistry and genomics

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2022
Adrenocortical carcinoma is a rare disease with poor prognosis whose clinical heterogeneity can at times present a challenge to accurate and timely diagnosis.
Ray Wang   +7 more
doaj   +1 more source

Venous thromboembolism in patients with adrenocortical carcinoma after surgery

open access: yesEndocrine Connections, 2020
Background: Adrenocortical carcinoma is a rare malignancy with a poor prognosis. We hypothesized that patients with adrenocortical carcinoma are at high risk for venous thromboembolism, given the numerous risk factors such as malignancy, abdominal ...
Jülide Durmuşoğlu   +5 more
doaj   +1 more source

Case Report: Surgery to remove adrenocortical oncocytic carcinoma from an Asian male

open access: yesFrontiers in Surgery, 2023
Adrenocortical oncocytic carcinoma is a rare type of adrenocortical tumor. Its clinical characteristics and biological behavior need to be further evaluated after the accumulation of cases.
Hongtao Liu   +3 more
doaj   +1 more source

Prominent 18F-FDG Uptake in the Adrenal Gland after Contralateral Adrenalectomy in a Known Case of Adrenocortical Oncocytic Carcinoma [PDF]

open access: yesAsia Oceania Journal of Nuclear Medicine and Biology, 2023
Adrenocortical carcinoma (ACC) is a rare type of cancer that is associated with a high rate of recurrence and poor prognosis. The main diagnostic approaches to adrenocortical cancer include CT scan, MRI and the promising role of 18F-FDG PET/CT.
Rakan Al-Rashdan   +3 more
doaj   +1 more source

Embolization in an adrenocortical carcinoma as palliative therapy [PDF]

open access: yes, 1999
Background: With an annual incidence of 0.2% of new cases per 100,000 inhabitants, adrenocortical carcinoma is rare. In advanced tumor only palliative treatment modalities are practicable. Because of scarcity of the tumor, standard treatment has not been
Braunschweig, R.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy